Last updated on May 2017

Psoriatic Arthritis – Inadequate response to biologic DMARDs

Brief description of study

Psoriatic Arthritis – Inadequate response to biologic DMARDs

Detailed Study Description

A research study is evaluating an investigational medication for psoriatic arthritis

This research study may be an option if you:
  • Are at least 18 years of age
  • Have a diagnosis of active psoriatic arthritis for at least 6 months
  • Have a history of or current plaque psoriasis
  • Have at least 3 tender and 3 painful joints
  • Have had an inadequate response to at least one bDMARD in the past (such as Adalimumab, Etanercept, Infliximab, Golimumab, or Certolizumab pegol)
  • Do not have a history of fibromyalgia, any arthritis with onset before age 17, or any other inflammatory joint conditions (such as gout, scleroderma, or lupus)

Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication at no cost.

Clinical Study Identifier: TX149472

Find a site near you

Start Over

PMG Research of Wilmington

1202 Medical Center Drive Wilmington, NC USA
  Connect »